| pubmed-article:1453202 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1453202 | lifeskim:mentions | umls-concept:C0008059 | lld:lifeskim |
| pubmed-article:1453202 | lifeskim:mentions | umls-concept:C0027819 | lld:lifeskim |
| pubmed-article:1453202 | lifeskim:mentions | umls-concept:C0337810 | lld:lifeskim |
| pubmed-article:1453202 | lifeskim:mentions | umls-concept:C1521808 | lld:lifeskim |
| pubmed-article:1453202 | lifeskim:mentions | umls-concept:C0008838 | lld:lifeskim |
| pubmed-article:1453202 | lifeskim:mentions | umls-concept:C0030927 | lld:lifeskim |
| pubmed-article:1453202 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:1453202 | lifeskim:mentions | umls-concept:C0205221 | lld:lifeskim |
| pubmed-article:1453202 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:1453202 | pubmed:dateCreated | 1993-1-7 | lld:pubmed |
| pubmed-article:1453202 | pubmed:abstractText | The objective of the present study was to determine whether an increase in the intensity of therapy improves outcome for children with disseminated poor-risk neuroblastoma. | lld:pubmed |
| pubmed-article:1453202 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1453202 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1453202 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1453202 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1453202 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1453202 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1453202 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:1453202 | pubmed:issn | 0732-183X | lld:pubmed |
| pubmed-article:1453202 | pubmed:author | pubmed-author:CarliMM | lld:pubmed |
| pubmed-article:1453202 | pubmed:author | pubmed-author:CasaleFF | lld:pubmed |
| pubmed-article:1453202 | pubmed:author | pubmed-author:Cordero di... | lld:pubmed |
| pubmed-article:1453202 | pubmed:author | pubmed-author:De BernardiBB | lld:pubmed |
| pubmed-article:1453202 | pubmed:author | pubmed-author:MarcheseNN | lld:pubmed |
| pubmed-article:1453202 | pubmed:author | pubmed-author:BagnuloSS | lld:pubmed |
| pubmed-article:1453202 | pubmed:author | pubmed-author:BrisigottiMM | lld:pubmed |
| pubmed-article:1453202 | pubmed:author | pubmed-author:CorciuloPP | lld:pubmed |
| pubmed-article:1453202 | pubmed:author | pubmed-author:De... | lld:pubmed |
| pubmed-article:1453202 | pubmed:author | pubmed-author:GaraventaAA | lld:pubmed |
| pubmed-article:1453202 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1453202 | pubmed:volume | 10 | lld:pubmed |
| pubmed-article:1453202 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1453202 | pubmed:authorsComplete | N | lld:pubmed |
| pubmed-article:1453202 | pubmed:pagination | 1870-8 | lld:pubmed |
| pubmed-article:1453202 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:1453202 | pubmed:meshHeading | pubmed-meshheading:1453202-... | lld:pubmed |
| pubmed-article:1453202 | pubmed:meshHeading | pubmed-meshheading:1453202-... | lld:pubmed |
| pubmed-article:1453202 | pubmed:meshHeading | pubmed-meshheading:1453202-... | lld:pubmed |
| pubmed-article:1453202 | pubmed:meshHeading | pubmed-meshheading:1453202-... | lld:pubmed |
| pubmed-article:1453202 | pubmed:meshHeading | pubmed-meshheading:1453202-... | lld:pubmed |
| pubmed-article:1453202 | pubmed:meshHeading | pubmed-meshheading:1453202-... | lld:pubmed |
| pubmed-article:1453202 | pubmed:meshHeading | pubmed-meshheading:1453202-... | lld:pubmed |
| pubmed-article:1453202 | pubmed:meshHeading | pubmed-meshheading:1453202-... | lld:pubmed |
| pubmed-article:1453202 | pubmed:meshHeading | pubmed-meshheading:1453202-... | lld:pubmed |
| pubmed-article:1453202 | pubmed:meshHeading | pubmed-meshheading:1453202-... | lld:pubmed |
| pubmed-article:1453202 | pubmed:meshHeading | pubmed-meshheading:1453202-... | lld:pubmed |
| pubmed-article:1453202 | pubmed:meshHeading | pubmed-meshheading:1453202-... | lld:pubmed |
| pubmed-article:1453202 | pubmed:meshHeading | pubmed-meshheading:1453202-... | lld:pubmed |
| pubmed-article:1453202 | pubmed:meshHeading | pubmed-meshheading:1453202-... | lld:pubmed |
| pubmed-article:1453202 | pubmed:year | 1992 | lld:pubmed |
| pubmed-article:1453202 | pubmed:articleTitle | Standard-dose and high-dose peptichemio and cisplatin in children with disseminated poor-risk neuroblastoma: two studies by the Italian Cooperative Group for Neuroblastoma. | lld:pubmed |
| pubmed-article:1453202 | pubmed:affiliation | Department of Hematology-Oncology, Giannina Gaslini Children's Hospital, Genova, Italy. | lld:pubmed |
| pubmed-article:1453202 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1453202 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1453202 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1453202 | lld:pubmed |
